Chimeric Antigen Receptor (CAR) Approaches to AD/ADRD (R61/R33 Clinical Trial Not Allowed) (RFA-AG-24-046)

Sponsor: National Institute on Aging

Due Date: February 07, 2024

Building Neuroscience Research Infrastructure for Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) in Africa (UG3/UH3 Clinical Trial Not Allowed) • (RFA-AG-24-027)

Sponsor: National Institute on Aging

Due Date: February 14, 2024

Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Require

Sponsor: National Institute on Aging

Due Date: November 19, 2026

Ruth L. Kirschstein NRSA Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) (PA-23-260)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31) (PA-23-272)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Analytical and Clinical Validation of Biomarkers for Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Optional) (PAR-23-258)

Sponsor: National Institute on Aging

Due Date: Multiple due dates; see announcement.

Notice of Participation of NIA in PAR-23-220, "SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required)" (NOT-AG-23-048)

Sponsor: National Institute on Aging

SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required) (PAR-23-220)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Health Equity and the Cost of Novel Treatments for Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (R61/R33 Clinical Trial Not Allowed) (RFA-AG-24-050)

Sponsor: National Institute on Aging

Due Date: LOI due September 29, 2023. Application due October 31, 2023.

NIH Blueprint and BRAIN Initiative Program for Enhancing Neuroscience Diversity through Undergraduate Research Education Experiences (BP BRAIN-ENDURE) (R25 Clinical Trial Not Allowed) (RFA-NS-24-014)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed) (PAR-23-219)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Notice of Special Interest: Administrative Supplements for the U.S.-Japan Brain Research Cooperative Program (BRCP) - U.S. Entity (Admin Supp) (NOT-NS-23-092)

Sponsor: National Institutes of Health

Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed) (PA-23-189)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

NIH Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed) (PAR-23-178)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional) (PAR-23-207)

Sponsor: National Institute of Mental Health, National Institute on Aging

Due Date: Multiple due dates; see announcement.